On July, 22, 2020 the Department of Chemistry and Applied Biosciences of the ETH Zürich, Switzerland announced the successful installation and acceptance of the Avance™ NEO 1.2 GHz NMR system. Following the acceptance of the world's first 1.2 GHz NMR at the CERM of the University of Florence earlier this year, this marks the second installation of a 1.2 GHz NMR in the world. ETH and research groups headed by professors Beat Meier, Matthias Ernst, and Alexander Barnes will utilize their new 1.2 GHz NMR system to enable the development of new solid-state NMR techniques, and to apply these techniques to study materials and biological systems, including proteins fibrils which are linked to diseases such as Parkinson’s and Alzheimer’s. The 1.2 GHz spectrometer will also be used as a basis for further improving NMR methodology towards in-cell structural biology, and to investigate solid catalysts and functional materials, e. g. for energy conversion and data storage. On the same day, July 22, 2020, the third 1.2 GHz NMR system was delivered to the Max Planck Institute for Biophysical Chemistry in Göttingen. Its installation is underway.
This is a reminder to apply for the Instruct-ERIC R&D Pilot Call - get funding of up to €15,000!
Closing 14:00 CEST on 15 April, the Instruct-ERIC R&D Funding Call invites early career researchers to submit proposals to access Instruct technology, equipment, and expertise from our 27 facilities across Europe for small scale pilot research projects in integrated structural biology.
Register now for the 32nd edition of the Instruct-ERIC Structure Meets Function webinar series, taking place on Zoom, 17 April at 11:00 CEST.
The latest webinar will have two speakers who have accessed the Instruct-ERIC facilities, expertise, and machinery via the ISIDORe project.
Talk 1: Nikitas Georgiou - National and Kapodistrian University of Athens
Title: Potential anti-inflammatory drugs
Talk 2: Séverine Padiolleau - Université de Technologie de Compiègne
Title: Identification of aptamers interacting with a protein target involved in lyme disease